In addition, we determined the relative expression levels of C-Myc and CyclinD1 because we hypothesized that CDCA3 is involved in the control of cell cycle-related proteins to carry out its biological role in cutaneous melanoma. The gene discussed is CCND1; the disease is cutaneous melanoma.